Is a Rite Aid RediClinic Coming to a Store Near You?

Rite Aid acquired RediClinic in February to launch into in-store health clinics. The company plans to open up to 70 clinics this year in a bid to better compete against CVS and Walgreen.

Jun 29, 2014 at 1:30PM

Rite Aid (NYSE:RAD) may be late in launching in-store health-care clinics, but Rite Aid may quickly make up ground on competitors CVS Caremark (NYSE:CVS) and Walgreen (NASDAQ:WBA) following its purchase of the Texas-based RediClinic in April.

The RediClinic deal gives Rite Aid a proven model that shortens the company's learning curve and catapults it into competition with its larger peers, so let's take a closer look at Rite Aid's plans for in-store health-care clinics.

G

Source: Rite Aid

First, a bit of background
RediClinic already operates successfully within 30 H.E.B. grocery stores in Texas, and based on Rite Aid's earnings conference call last week, the company is pressing forward with rolling out RediClinics in its stores soon.

The market for in-store clinics is intriguing. Historically, under-insured patients and patients needing off-hour care have made their way to pricey hospital emergency rooms.

Now that health-care reform is adding millions of new Medicaid and private insurance members, urgent care and in-store clinics have the potential to win away business from those emergency rooms as insurers direct consumers to lower-cost alternatives.

Rite Aid is already seeing a wave of new patients thanks to reform. In its most recent quarter, the company reported that its pharmacy script volume rose 2.3% in the past year, with a major driver of that growth being new Medicaid patients in the 26 states that embraced Medicaid expansion as part of Obamacare.

That early success suggests that RediClinic could see dramatic sales growth out-of-the-gate, giving Rite Aid a quicker return on investment than CVS and Walgreen, which have had to work hard over the past couple years to carve out the in-store clinic niche, without the advantage of reform.

G

Source: RediClinic.

Plans for a rollout
Rite Aid has run the numbers and expects that adding a RediClinic to its stores will cost roughly $200,000 per store.

In return for that investment, RediClinics will not only generate revenue on their own by providing basic health care services using nurse practitioners, but also by driving prescriptions and OTC medicine sales.

Rite Aid's RediClinic roll-out plans include opening 70 in-store clinics over the next 18 months. Those clinics will be launched in Rite Aid stores that have already been remodeled into the company's new (and highly successful) wellness format.

According to the company, those new wellness remodeled stores are outperforming legacy stores. Front-end sales and prescription volume at wellness stores were 2.6% and 1.2% higher than at non-wellness stores last quarter, respectively. Adding clinics to these top-performing stores should further boost same-store sales, providing additional margin friendly leverage.

Fool-worthy final thoughts
Rite Aid has also previously said it would consider opening additional RediClinics in non-Rite Aid stores. That suggests that RediClinic could continue to capture market share in Texas by expanding into other H.E.B. locations (H.E.B. operates stores in 150 communities). It could also conceivably serve as a launch pad for Rite Aid to enter other important retiree markets like Florida, where it's currently absent. Publix, one of Florida's largest grocers, had previously hosted 40 Little Clinics until it pulled the plug on leases in 2011 following Little Clinics' sale to competitor Kroger.

Rite Aid won't surpass CVS or Walgreen's clinic market share anytime soon. CVS already operates 800 MinuteClinics (with a goal of 1,500 by 2017) and Walgreen plans to operate more than 500 by year end, but Rite Aid's RediClinic's should provide additional tailwinds to the company's growth for years to come, and that should prove profit-friendly.

Even Rite Aid may have a hard time keeping up with this stock
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

 

Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends CVS Caremark. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers